Applications published 9 January 2008

• Topical compsn detection
Johnson & Johnson Consumer Companies 1874261*

• Antimicrobial formulations
Syntopix 1874262*

• Methods for generating new hair follicles, treating baldness, and hair removal
The Trustees of the University of Philadelphia 1874265*

• Injectable depot formulations and methods for providing sustained release of poorly soluble drugs comprising nanoparticles
Pfizer 1871267*

• Injectable depot formulations and methods for providing sustained release of nanoparticle compsns
Pfizer 1874268*

• Combination of tramadol and substances that comprise gabapentin
Alza 1874269*

• Pharmaceutical aerosol compsn
Pari Pharma 1874270*

• Modified release compsns comprising a fluorocytidine derivative for the treatment of cancer
Elan Pharma International 1874271*

• Nanoparticulate and controlled release compsns comprising prostaglandin derivatives
Elan Pharma International 1874272*

• Gastroresistant pharmaceutical formulations containing rifaximin
Alfa Wassermann 1874273*

• Matrix-based pulse release pharmaceutical formulation
Mallinckrodt 1874274*

• Compsns and methods for stabilising active pharmaceutical ingredients
McNeil-PPC 1874275*

• Sustained release L-arginine formulations and methods of manufacture and use
Palmetto Pharmaceuticals 1874277*

• Compsns containing micronised tanaproget
Wyeth 1874278*

• Water-soluble films comprising nicotine
BioProgress Technology 1874279*

• Topical treatment with NGF and DHA in damaged corneas
Board of Supervisors of Louisiana State University and Agricultural and Mechanical College; Bazan, Haydee; Bazan, Nicholas 1874280*

• Optimising pharmacodynamics of therapeutic agents for treating vascular tissue
Carter Andrew 1874281*

• Methods and compsns for treatment of CNS disorders
Adamas Pharmaceuticals 1874282*

• Use of novel compounds for IBD treatment
Ferring 1874283*

• Eutectic blends containing a water soluble vitamin derivative
Eastman Chemical 1874284*

• Complementary compsns to reduce blood glucose levels and treat diabetes
Astrum Therapeutics 1874285*

• Methods and compsns for the treatment of anxiety disorders
Neurotherapeutics Pharma 1874286*

• Compounds and compsns for use in the prevention and treatment of obesity and related syndromes
Innodia 1874287*

• Acetyl L-carnitine for preventing painful peripheral diabetic neuropathy
Sigma-Tau Industrie Farmaceutiche Riunite 1874288*

• Reduction in complement activation and inflammation during tissue injuries by carotenoids, carotenoid analogues, or derivatives thereof
Cardax Pharmaceuticals 1874289*

• A process for the preparation of an oxaplatin preparation
Vuab Pharma 1874290*

• Novel use of zinc gluconate for treating hydradentis suppurativa
Labcatal 1874291*

• Methods for modulating bladder function
Wyeth 1874292*

• Association between ferroquine and an artemisine derivative for treating malaria
Sanofi-Aventis 1874293*

• Benzothiophene hydroxamic acid derivatives with carbamate, urea, amide and sulphonamide substitutions
Merck 1874294*

• Benzothiophene derivatives
Merck 1874295*

• Method of treating multiple myeloma using 17-AAG of 17-AG of a prodrug of either
Kosan Biosciences 1874296*

• Method of treating multiple myeloma using 17-AAG or 17-AG or a prodrug of either in combination with a proteasome inhibitor
Kosan Biosciences 1874297*

• Methods and compsns for production, formulation and use of 1-aryl-3-azabicyclo[3,1,0]hexanes
DOV Pharmaceutical 1874298*

• VLA-4 antagonists
Merck 1874299*

• Method for treating apathy syndrome
Hamilton Pharmaceuticals 1874300*

• Niacin receptor agonists, compsns containing such compounds and methods of treatment
Merck 1874301*

• Angiotensin II receptor antagonists
Merck 1874302*

• Pyrazole compounds as prostaglandin receptor ligands
Glaxo Group 1874303*

• Benzotriazole derivatives as cannabinoid antagonists
Jenssen Pharmaceutica 1874304*

• Substituted oxazole derivatives and their use as tyrosine kinase inhibitors
AB Science 1874305*

• Compsns of an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
PTC Therapeutics 1874306*

• Use of a sulphonamide compound for improving the pharmacokinetics of a drug
Tibotec Pharmaceuticals 1874307*

• Roflumilast for the treatment of diabetes mellitus
Nycomed 1874308*

• Roflumilast for the treatment of pulmonary hypertension
Nycomed 1874309*

• Opioid receptor agonist compounds and their use in treatment of pain
Research Triangle Institute 1874310*

• A method of preventing, delaying or reverting abnormal amyloid deposition
Research & Innovation Soc. Coop. 1874311*

• Methods and means for the treatment of HPV induced intraepithelial neoplasis
Leiden University Medical Centre 1874312*

• Treatment or prevention of ovarian hyperstimulation syndrome (OHSS) using a dopamine agonist
Ferring International Centre 1874313*

• Pellet-type controlled release preparation containing cinnarizine and dimenhydrinate for combating vertigo
Hennig Arzneimittel 1874314*

• Compsns of novel opioid compounds and method of use thereof
Mount Cook Biosciences 1874315*

• Use of PDE-5 inhibitors for endothelial repair of tissues impaired by trauma or disease
Associazione Foresta Per La Ricerca Nell Riproduzione Umana 1874316*

• Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
Bayer Pharmaceuticals 1874317*

• N-alkyl-azacycloalkyl NMDA/NR2B antagonists
Merck 1874318*

• Formulations of quaternary ammonium neuromuscular blocking agents
Lyotropic Therapeutics 1874319*

• Compsn of film-forming solution type, comprising vitamin D or a derivative thereof and a corticosteroid, and use thereof in dermatology
Galderma 1874320*

• Compsn for the treatment of neoplasms
CombinatoRx Inc 1874321*

• Use of TAFI inhibitors for enhanced mytocardial reperfusion and facilitated PCI
Bayer Schering Pharma Aktiengesellschaft 1874322*

• Tamponade compsns and methods for retinal repair
Kadrmas, Eddie 1874323*

• Method for treating advanced ovarian cancer with doxorubicin entrapped in liposomes
Alza 1874324*

• Methods for treating infectious disease exacerbated asthma
Coley Pharmaceutical; Sanofi-Aventis 1874325*

• Use of devil’s claw (harpagophytum procumbens) root extracts for endometriosis treatment
Riemser Arzneimittel 1874326*

• Antiviral peptides
Campina Nederland Holding 1874327*

• Use of a peptide in the form of a slimming active principle
Société d’Extraction des Principes Actifs 1874328*

• Blood pressure lowering hydrolysates
DSM IP Assets 1874329*

• Peptides that down-regulate the activity of plasma membrane transporters including sodium-D-glucose cotransporter SGLT1
Julius-Maximilians-Universität Würzburg 1874330*